Perkins Coie LLP
07/26/2021 | News release | Archived content
Andrew Kline Mentioned in Law360—DEA Should Allow Psychedelic Therapy, 9th Circ. Told
Andrew Kline was mentioned in 'DEA Should Allow Psychedelic Therapy, 9th Circ. Told,' an article in Law360*, regarding the use of Schedule I substances such as psychedelics for specific, medicinal purposes.
'According to the patients' reply brief, the Controlled Substances Act must give way to a 2018 federal 'Right to Try' law and similar state laws that allow eligible patients to use drugs that have not been approved by federal regulators. Furthermore, the patients argued, the DEA's inflexibility on the issue makes it ripe for judicial review, despite the agency's pleadings that it had not rendered a final and definitive action and attempt to punt the present dispute to administrative review.'
*Subscription-based publication